📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Inhibitor of serine peptidase 2 enhances Leishmania major survival in the skin through control of monocytes and monocyte-derived cells. (2018)

First Author: Goundry A
Attributed to:  Proteolysis and life cycle progression in Leishmania funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1096/fj.201700797r

PubMed Identifier: 29097502

Publication URI: http://europepmc.org/abstract/MED/29097502

Type: Journal Article/Review

Volume: 32

Parent Publication: FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Issue: 3

ISSN: 0892-6638